Cancer Genomics
CancerRiskDx™
Hereditary Cancer Screening
Detect hereditary cancer risks and take control of your health for a brighter, healthier future.
Testing for tomorrow
CancerRiskDx™ is a genetic test for those who want to know more about their risk of developing cancer, why it might be common in their family, or want to inform treatment options following a cancer diagnosis. CancerRiskDx™ screens for genes associated with increased risk for common hereditary cancers. Our CancerRiskDx™ multi-cancer panels include commonly screened-for genes associated with 125 types of cancer.
01
Know your risk
Approximately 5 to 10 percent of all cancers
can be attributed to inherited variants or
mutations.1 Patterns of cancer can be seen in families where people have these mutations.
02
Inherited mutations and cancer risk
Certain genetic mutations passed down in families can greatly increase a person’s chance of developing cancers such as breast, ovarian, or colorectal cancer during their lifetime.
03
High risk for hereditary cancer are not tested
Despite the benefits of early detection and prevention, many high-risk patients are never tested for hereditary cancer, leaving them unaware of their elevated risk.
04
99.9% Accuracy
Identifying cancer at an early stage gives you vital insights to better manage your risks and reduce the chance of secondary cancers. All selected genes are analyzed using next-generation sequencing (NGS) with 99.9% accuracy, ensuring minimal potential for error.
Comprehensive Hereditary Cancer Screen
CancerRiskDx™ Hereditary Cancer Test may help you understand why your cancer developed and what treatment options are available to you. This information can help you make informed decisions, in partnership with your doctors, about your therapy and surveillance options. This knowledge can help you talk to your family members about their cancer risks.
CancerRiskDx™ detect >99.9% of described mutations in the included genes, when present (analytic sensitivity).
When to Consider CancerRiskDx™ Testing
Genetic testing is recommended when there are patterns that suggest an increased risk for hereditary cancers. You may consider testing if any of the following apply.
-
Personal or family history of cancer at age 50 or younger.
-
Personal or family history of ovarian, breast, pancreatic, colorectal, lung, or metastatic prostate cancer.
-
Multiple cancers or tumors on the same side of the family.
-
You are concerned about personal or family history of cancer.
Any Questions
Transform Cancer Care with Precision Medicine
Our comprehensive genomic profiling tests provide information about clinically relevant biomarkers and genomic alterations to help match patients to approved targeted therapies, immunotherapies, and clinical trial options — giving physicians and patients powerful actionable insights for navigating cancer care.